A better world starts with more equitable global health. Impact Global Health is an essential partner, collaborator and counsel to anyone looking to positively impact historically neglected and underfunded health issues.
About usDiscover the insights that two decades of global health data have given us.
Gender bias in R&D means that women's health is suffering. The conditions and experiences which disproportionately, differently or exclusively affect women are persistently overlooked, leading to worse health outcomes and social and economic inequities. We've launched this hub to look at the whole picture.
The G-FINDER 2023 report on sexual & reproductive health R&D funding shows that it is not equal: the numbers for non-maternal conditions have enjoyed growth since 2018, while investment in maternal health has languished.
Read the report
Data
G-FINDER is the gold-standard tracker of R&D funding for new products and technologies for global health. Updated annually, this is the evidence base informing all global health advocacy, investment and policy change.
The case for change: Explore funding trends over time, where there is innovation and where there are gaps.
Drivers of impact: Understand which initiatives are gaining strength and where there are weaknesses in global health R&D impact.
Explore G-FINDER dataApproved products and technologies, as well as candidates in the development pipeline, for global health priorities.
Critical medicines, diagnostics and drugs approved and in the development pipeline for the most significant pregnancy-related conditions
Snakebite envenoming medicines investigated or approved since 2015.
News and opinions from the world of global health R&D.
5 min read
Join us for an online webinar as we launch the latest G-FINDER report on neglected diseases R&D. We will present the latest analysis of the funding landscape and explore how smart investment decisions can be made to deliver the greatest impact. Thursday 30 January, 2025 13:00-14:30 GMT
20 min read
Our Director, Science & Policy, Dr Lindsay Keir, looks at the lessons of COVID-19 and asks whether our response to the recent mpox outbreak shows that we have learned?
5 min read
Dr Alex Asamoah Ankomah, our Technical Officer in the Science & Policy Advisory team, examines the transformative potential of monoclonal antibodies (mAbs) in combatting infectious diseases and highlights their promise despite challenges in cost and access, particularly in LMICs
Impact Global Health develops practical frameworks and tools which you can use to do your own analyses and draw your own conclusions about the most effective ways to impact global health.
The first comprehensive assessment framework of impact metrics for global health R&D, developed over two years with a global network of collaborators.
Developed with the International Pandemic Preparedness Secretariat, this scorecard takes the pulse of the world's readiness to make diagnostics, therapeutics, and vaccines globally available within the first 100 days of a pandemic threat.
NEW BRAND KIT AVAILABLE
Join us in creating global health impact for the world's neglected diseases and conditions with our media and communications resources and tools.